1. Home
  2. SHOP vs NVO Comparison

SHOP vs NVO Comparison

Compare SHOP & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shopify Inc.

SHOP

Shopify Inc.

HOLD

Current Price

$170.26

Market Cap

222.4B

Sector

Technology

ML Signal

HOLD

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$52.29

Market Cap

212.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHOP
NVO
Founded
2004
1923
Country
Canada
Denmark
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
222.4B
212.7B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
SHOP
NVO
Price
$170.26
$52.29
Analyst Decision
Buy
Buy
Analyst Count
32
11
Target Price
$165.06
$54.25
AVG Volume (30 Days)
6.2M
15.8M
Earning Date
02-10-2026
02-04-2026
Dividend Yield
N/A
2.35%
EPS Growth
28.16
10.06
EPS
1.36
3.67
Revenue
$10,696,000,000.00
$49,580,393,058.00
Revenue This Year
$31.77
$7.25
Revenue Next Year
$23.71
$0.24
P/E Ratio
$126.04
$14.30
Revenue Growth
30.25
16.64
52 Week Low
$69.84
$43.08
52 Week High
$182.19
$93.80

Technical Indicators

Market Signals
Indicator
SHOP
NVO
Relative Strength Index (RSI) 60.26 61.66
Support Level $166.91 $47.59
Resistance Level $172.98 $53.63
Average True Range (ATR) 5.96 1.19
MACD 0.83 0.56
Stochastic Oscillator 84.70 82.85

Price Performance

Historical Comparison
SHOP
NVO

About SHOP Shopify Inc.

Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: